Leibniz-Institut für Virologie (LIV)

A new study led by Prof. Sabine Windhorst’s group, in collaboration with Dr. Roland Thuenauer and Dr. Rudolph Reimer from the Leibniz-Institut für Virologie (LIV) Hamburg - home to the Nikon Centre of Excellence #NCofE - sheds new light on cancer cell communication. This research in the Journal of Extracellular Vesicles has uncovered a novel pathway for the oncogene CEP55 to enter cancer cell exosomes. Leveraging Nikon’s state-of-the-art imaging technology, the team used: 🔬 Ti2 microscope with CSU-W1 SoRa for high-resolution live-cell imaging 🔬 AX/AX R with Nikon Spatial Array Confocal (NSPARC) for detailed cellular visualisation 🔬 A1+ microscope for correlative light and electron microscopy (CLEM) Their findings reveal that CEP55 follows a non-canonical trafficking route, rather than the traditional early-to-late endosome pathway. This discovery enhances our understanding of cellular communication in cancer and could help pave the way for new therapeutic strategies. Congratulations to all the authors on this important achievement! 👏 Read the full article: https://lnkd.in/ezJYhVxT Dahlstroem, C. et al. (2025) ‘Mechanism of centrosomal protein 55 (CEP55) loading into exosomes’, J. Extracell. Vesicles, 14(2). doi:10.1002/jev2.70046. #NikonScienceSpotlight #NikonMicroscopy #CancerResearch #Exosomes #CellBiology

Last week, we had the pleasure of participating in the Trends in Microscopy 2025 #TiM2025 in Münsingen, Germany, where we showcased our latest advancements in bioimaging 🔬 A special thanks to our collaborator, Dr. Christian Conze at Nikon Centre of Excellence #NCofE at Leibniz-Institut für Virologie (LIV), for his invaluable support and insights! The workshop was completely booked, and attendees were deeply impressed by the Nikon Spatial Array Confocal #NSPARC detector in combination with our resonant scanning and the multi-immersion lens made for tissue clearing. 📸 Check out the photos from our sessions!

**Das LIV stellt sich vor** Wie hilft Bioinformatik, virale Strukturen besser zu verstehen? Prof. Maya Topf und ihr Team von der Abteilung "Integrative Virologie" erklären es im ersten Video unserer LIV-Kurzvorstellungen. Leibniz-Institut für Virologie (LIV) & Centre for Structural Systems Biology CSSB https://lnkd.in/ezWdTP84

**Vogelgrippe in den USA** In der WirtschaftsWoche werden aktuelle Herausforderungen der US-Eierindustrie & Maßnahmen zur Eindämmung des Virus beleuchtet, u.a. mit Influenza-Expertin Prof. Gülşah Gabriel Leibniz-Institut für Virologie (LIV) & Leibniz-Lab Pandemic Preparedness. https://lnkd.in/eaukeVTi

**Neuer Look für das Leibniz Center Infection (LCI)** Die LCI-Webseite ist nach einem großen Update jetzt übersichtlicher, moderner und informativer: www.lc-infection.de Als strategische Allianz vereint das LCI die Expertise von drei führenden Forschungseinrichtungen: 🔹 Leibniz-Institut für Virologie (LIV) 🔹 Bernhard Nocht Institute for Tropical Medicine (BNITM) 🔹 Forschungszentrum Borstel, Leibniz Lungenzentrum (FZB) Gemeinsam setzen wir neue Impulse in der Infektionsforschung und tragen zur Entwicklung innovativer Lösungen für globale Gesundheitsherausforderungen bei.

How can #EUfunded initiatives like REPO4EU help to advance innovative, efficient and affordable treatments for #RareDiseases? Dr. Kay Grünewald, Professor at University of Hamburg and Head of 'Structural Cell Biology of Viruses' Research Unit at Leibniz-Institut für Virologie (LIV), was interviewed by Norddeutscher Rundfunk on #RareDiseaseDay to discuss the role that #DrugRepurposing is playing in #RareDiseaseResearch. He highlighted how patients could benefit from the mechanistic approach being developed by research and innovation projects with a focus on drug repurposing, like REPO4EU and REMEDi4ALL. Listen to the episode (in German) ➡️ https://lnkd.in/erpj3W3s

In der letzten Folge des Podcasts "Coronavirus-Update" spricht Prof. Gülşah Gabriel (Leibniz-Institut für Virologie (LIV) & Leibniz-Lab Pandemic Preparedness) über die aktuellen Risiken der Vogelgrippe H5N1. Sie hebt die Dringlichkeit verstärkter Forschungsinitiativen in Europa als essenziellen Beitrag zur globalen Gesundheitsvorsorge hervor – genau wie die Förderung des wissenschaftlichen Nachwuchses in der Influenza-Forschung. https://lnkd.in/eHxpWV7g

Job Alert! **Leiter*in Finanzen und Drittmittelverwaltung (m/w/d)** Mehr Infos hier: https://lnkd.in/eUbbp7Sw ©Adobe Stock Visual Generation

🌟 Meet our first PI and project coordinator: Stephanie Pfänder! 🌟 We’re excited to highlight Stephanie’s work, who leads a research group focused on virus-host interactions. Her team utilizes advanced cellular models, including 3D organoids, to replicate native tissue environments – providing deeper insights into how viruses interact with human cells. By identifying host dependency and restriction factors, Stephanie’s research bridges the gap between molecular virology and real-world clinical applications, paving the way for innovative antiviral strategies. 🔬 Learn more about her work at the Leibniz-Institut für Virologie (LIV): 👉 https://lnkd.in/esaA36nr 🦋 Check out her Bluesky account as well: https://lnkd.in/e3upaCsb